Estimation of intradermal disposition kinetics of drugs: I. Analysis by compartment model with contralateral tissues

Pharmaceutical Research

Volumn 16, Issue 2, 1999, Pages 302-308

  Nakayama, Kazuki ^a   Matsuura, Hisae ^a   Asai, Masahide ^a   Ogawara, Ken ichi ^a   Higaki, Kazutaka ^a   Kimura, Toshikiro ^a  

^a OKAYAMA UNIVERSITY   (Japan)

Author keywords

Direct penetration; Intradermal disposition; Stripped skin; Systemic absorption

Indexed keywords

AMINOPHENAZONE; PHENAZONE;

ANIMAL EXPERIMENT; ARTICLE; COMPARTMENT MODEL; DRUG ABSORPTION; DRUG BLOOD LEVEL; DRUG DISPOSITION; DRUG DISTRIBUTION; DRUG PENETRATION; DRUG TISSUE LEVEL; DRUG UPTAKE; INTRAVENOUS DRUG ADMINISTRATION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SKIN ABSORPTION; STRATUM CORNEUM; TISSUE DISTRIBUTION; TOPICAL DRUG ADMINISTRATION;

EID: 0033043643     PISSN: 07248741     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1018844928818     Document Type: Article

References (21)

1. 1. M. Hashida, E. Mukai, T. Kimura, and H. Sezaki. Enhanced delivery of mitomycin C prodrugs through the skin. J. Pharm. Pharmacol. 37:542-544 (1985).
2. 2. S. Y. Chan and A. Li Wan Po. Prodrugs for dermal delivery. Int. J. Pharm. 55:1-16 (1989).
3. 3. F. Palagiano, L. Arenare, F. Barbato, M. I. La Rotonda, F. Quaglia, F. P. Bonina, L. Montenegro, and P. de Caprariis. In vitro and in vivo evaluation of terpenoid esters of indomethacin as dermal prodrugs. Int. J. Pharm. 149:171-182 (1997).
4. 4. A. C. Williams and B. W. Barry. Skin absorption enhancers. Crit. Rev. Ther. Drug Carrier Sys. 9:305-353 (1992).
5. 5. N. Ohara, K. Takayama, Y. Machida, and T. Nagai. Combined effect of d-limonene and temperature on the skin permeation of ketoprofen. Int. J. Pharm. 105:31-38 (1994).
6. 6. Y. Nakamura, K. Takayama, K. Higashiyama, T. Suzuki, and T. Nagai. Promoting effect of O-ethylmenthol on the percutaneous absorption of ketoprofen. Int. J. Pharm. 145:29-36 (1996).
7. 7. J. Hadgraft, K. A. Walters, and P. K. Wotton. Facilitated transport of sodium salicylate across an artificial lipid membrane by Azone. J. Pharm. Pharmacol. 37:725-727 (1985).
8. 8. Y. W. Chien, O. Siddiqui, W. M. Shi, P. Lelawongs, and J. C. Liu. Direct current iontophoretic transdermal delivery of peptide and protein drugs. J. Pharm. Sci. 78:376-383 (1989).
9. 9. P. Singh, M. S. Roberts, and H. I. Maibach. Modelling of plasma levels of drugs following transdermal iontophoresis. J. Contr. Rel. 33:293-298 (1995).
10. 10. J. E. Riviere and M. C. Heit. Electrically-assisted transdermal drug delivery. Pharm. Res. 14:687-697 (1997).
11. 11. B. W. Barry. Lipid-protein-partitioning theory of skin penetration enhancement. J. Contr. Rel. 15:237-248 (1991).
12. 12. J. Radermacher, D. Jentsch, M. A. Scholl, T. Lustinetz, and J. C. Frolich. Diclofenac concentrations in synovial fluid and plasma after cutaneous application in inflammatory and degenerative joint disease. Br. J. Clin. Pharmacol. 31:401-418 (1991).
13. 13. M. Dawson, C. M. McGee, J. H. Vine, P. Nash, T. R. Watson, and P. M. Brooks. The disposition of biphenylacetic acid following topical application. Eur. J. Clin. Pharmacol. 33:639-642 (1988).
14. nd ed.), Marcel Dekker, New York, 1989, pp. 511-529.
15. 15. P. Singh and M. S. Roberts. Dermal and underlying tissue pharmacokinetics of salicylic acid after topical application. J. Pharmacokinet. Biopharm. 21:337-373 (1993).
16. 1-independent multispecific anion transporter mediates active transport of pravastatin into rat liver. Am. J. Physiol. 264:G36-G44 (1993).
17. 17. K. Yamaoka and T. Nakagawa. A nonlinear least squares program based on differential equations, MULTI(RUNGE), for microcomputers. J. Pharmacobio-Dyn. 6:595-606 (1983).
18. 18. T. Iga, Y. Sawada, and Y. Sugiyama. Physiological pharmacokinetics: the method of parameter calculation. In M. Hanano, T. Umemura, and T. Iga (eds.). Applied Pharmacokinetics: Theory and Experiments, Soft Science Inc., Tokyo, 1985, pp. 431-473.
19. 19. K. Yamaoka, T. Nakagawa, and T. Uno. Application of Akaike's information criterion (AIC) in the evaluation of linear pharmacokinetic equations. J. Pharmacokinet. Biopharm. 6:165-175 (1978).
20. 20. P. Singh and M. S. Roberts. Dermal and underlying tissue pharmacokinetics of lidocaine after topical application. J. Pharm. Sci. 83:774-782 (1994).
21. 21. P. Singh and M. S. Roberts. Local deep tissue penetration of compounds after dermal application: structure-tissue penetration relationships. J. Pharmacol. Exp. Ther. 279:908-917 (1996).